Standard Vascepa Dosing
Vascepa (icosapent ethyl) is approved at 4 grams per day, taken as 2 grams (4 capsules of 0.5 grams each) twice daily with food. This applies regardless of statin use for reducing cardiovascular risk in adults with elevated triglycerides (≥150 mg/dL) on top of statin therapy and other lifestyle measures.[1]
Dosing When Combined with Statins
No dosage adjustment is required or recommended for Vascepa when used with statins. The pivotal REDUCE-IT trial, which supported FDA approval, tested 4 grams daily specifically in statin-treated patients with high triglycerides and established cardiovascular disease or risk factors. Statin intensity (high, moderate, or low) did not alter the 4-gram regimen, and outcomes showed consistent cardiovascular benefits.[1][2]
Adjustments for Other Factors
Renal or hepatic impairment may require dose changes: reduce to 2 grams daily for severe renal issues (eGFR <30 mL/min) or moderate liver problems (Child-Pugh B). No specific statin-related pharmacokinetic interactions necessitate changes, as Vascepa does not affect statin metabolism significantly.[1]
Why No Change with Statins?
Vascepa targets triglyceride-rich lipoproteins independently of statins, which primarily lower LDL cholesterol. Co-administration is standard in guidelines from the American College of Cardiology for high-risk patients, with the 4-gram dose optimized for additive risk reduction without dose tweaking.[2][3]
[1]: Vascepa Prescribing Information (Amarin Pharma)
[2]: REDUCE-IT Trial (NEJM, 2019)
[3]: ACC Expert Consensus on High TG Management (2016, updated)